Institut Jules Bordet is a specialized general hospital and research institute of the Université libre de Bruxelles which specializes in oncology. It is located in Brussels, Belgium.

During the past decade, Institut Jules Bordet Clinical Trials Conduct Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Institut Jules Bordet Clinical Trials Conduct Unit" are "Advanced Solid Tumor" (1 trials), "Biliary Tract Cancer (BTC)" (1 trials), "Cervical Cancer" (1 trials), "Colorectal Cancer (CRC)" (1 trials) and "Cutaneous Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "Institut Jules Bordet Clinical Trials Conduct Unit" in a lesser frequency.

Most popular intervention types in "Institut Jules Bordet Clinical Trials Conduct Unit" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracil" (1 trials), "Cisplatin" (1 trials), "Gemcitabine" (1 trials), "INCB001158" (1 trials) and "INCB099280" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Jules Bordet Clinical Trials Conduct Unit" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Institut Jules Bordet Clinical Trials Conduct Unit". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Institut Jules Bordet Clinical Trials Conduct Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut Jules Bordet Clinical Trials Conduct Unit, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".